Eli Lilly stock price target maintained at $825 by Cantor Fitzgerald
PositiveFinancial Markets

Eli Lilly's stock price target has been maintained at $825 by Cantor Fitzgerald, reflecting confidence in the company's growth and performance. This stability in target price is significant for investors as it suggests a strong outlook for Eli Lilly, especially in the context of ongoing developments in the pharmaceutical industry.
— Curated by the World Pulse Now AI Editorial System